Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-01-27 00:00:00 ET · period of report 2025-01-23 · accession 0001415889-25-002137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-27 | 2025-01-24 | MIRM | Radovich Peter | Pres AND COO | S - Sale+OE | $47.92 | -3,177 | 29.6K | -10% | -$152.2K |
| D | 2025-01-27 | 2025-01-23 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | — | +5,750 | 32.8K | +21% | — |
| D | 2025-01-27 | 2025-01-23 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $0.00 | -5,750 | 11.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-24 | S | D | 3,177 | $47.92 | 29,588 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-23 | M | A | 5,750 | — | 32,765 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 3 | Derivative | Restricted Stock Units | 2025-01-23 | M | D | 5,750 | $0.00 | 11,500 | D | — · — to — | 5,750 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. |